These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 17674458)
21. Out in the open. Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130 [No Abstract] [Full Text] [Related]
22. Influence and drug marketing. Sauri M Md Med; 2005; 6(1):24-5. PubMed ID: 15869104 [No Abstract] [Full Text] [Related]
23. The new and ever changing PhRMA guidelines are impeding productive relationship. Cheson BD Clin Adv Hematol Oncol; 2009 Jun; 7(6):350. PubMed ID: 19645132 [No Abstract] [Full Text] [Related]
24. Rx for compliance. How the new PhRMA code on permissible pharmaceutical marketing practices affects your organization. Zimmerman HM MGMA Connex; 2003 Feb; 3(2):54-7, 1. PubMed ID: 12602196 [TBL] [Abstract][Full Text] [Related]
25. No more free lunches: the market has us all in its grip. Madhavan KS BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907501 [No Abstract] [Full Text] [Related]
26. Debunking myths in physician-industry conflicts of interest. Lichter PR Am J Ophthalmol; 2008 Aug; 146(2):159-71. PubMed ID: 18538299 [TBL] [Abstract][Full Text] [Related]
27. Donations of Expensive Equipment for Resident Training. Reddy AK AMA J Ethics; 2015 Aug; 17(8):734-8. PubMed ID: 26270872 [No Abstract] [Full Text] [Related]
28. ACOG Committee Opinion No. 401: Relationships with industry. American College of Obstetricians and Gynecologists Committee on Ethics Obstet Gynecol; 2008 Mar; 111(3):799-804. PubMed ID: 18310391 [No Abstract] [Full Text] [Related]
29. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts). Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449 [No Abstract] [Full Text] [Related]
30. Off-label or off-limits? Ratner M; Gura T Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236 [No Abstract] [Full Text] [Related]
31. [The influence of the pharmaceutical industry on treatment guidelines]. Smulders YM; Thijs A Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2429-31. PubMed ID: 18064860 [TBL] [Abstract][Full Text] [Related]
32. Meeting US and European supplier control requirements. Donawa M Med Device Technol; 2009; 20(3):24-7. PubMed ID: 19626952 [TBL] [Abstract][Full Text] [Related]
33. Are we providers or physicians? Baxter JD Arch Intern Med; 2009 Oct; 169(18):1725. PubMed ID: 19822834 [No Abstract] [Full Text] [Related]
34. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine. Rubin EB; Bernat JL Headache; 2008; 48(10):1545-9. PubMed ID: 19076654 [No Abstract] [Full Text] [Related]
35. Relationships with the drug industry: Focus on better information. Tiner R BMJ; 2009 Feb; 338():b252. PubMed ID: 19193617 [No Abstract] [Full Text] [Related]
36. Guidelines on gifts to physicians from industry: an update. Council on Ethical and Judicial Affairs of the American Medical Association Food Drug Law J; 2001; 56(1):27-40. PubMed ID: 11942349 [No Abstract] [Full Text] [Related]
38. [Medication on the threshold. Communication between physician and drug industry]. Everse JW Ned Tijdschr Geneeskd; 1969 Oct; 113(41):1778-84. PubMed ID: 5344633 [No Abstract] [Full Text] [Related]
39. Comment: interactions between the medical profession and the pharmaceutical industry in Australia. Kerridge I Australas Psychiatry; 2008 Jun; 16(3):166-8. PubMed ID: 18568620 [No Abstract] [Full Text] [Related]